251 results on '"Melloni,Elisabetta"'
Search Results
2. Microfluidic Fabricated Liposomes for Nutlin-3a Ocular Delivery as Potential Candidate for Proliferative Vitreoretinal Diseases Treatment
3. Microfluidic Fabricated Liposomes for Nutlin-3a Ocular Delivery as Potential Candidate for Proliferative Vitreoretinal Diseases Treatment
4. Evaluation of Anticancer Activity of Nucleoside–Nitric Oxide Photo-Donor Hybrids.
5. Cyclooxygenase-2 Expression is Induced during Human Megakaryopoiesis and Characterizes Newly Formed Platelets
6. Supplementary Data from miR-34a Induces the Downregulation of Both E2F1 and B-Myb Oncogenes in Leukemic Cells
7. Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model
8. Supplementary Table S1 from Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway
9. Supplementary Methods from C-Reactive Protein Downregulates TRAIL Expression in Human Peripheral Monocytes via an Egr-1–Dependent Pathway
10. Palmitic Acid Induced a Long-Lasting Lipotoxic Insult in Human Retinal Pigment Epithelial Cells, which Is Partially Counteracted by TRAIL
11. Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation
12. Editor's Note: The Oncogene DEK Promotes Leukemic Cell Survival and Is Downregulated by Both Nutlin-3 and Chlorambucil in B-Chronic Lymphocytic Leukemic Cells
13. Editor's Note: Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway
14. In Human Lymphatic Glycocalyx Identification by Electron Microscopy and Immunohistochemistry
15. Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells
16. Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity?
17. New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib
18. Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids
19. The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40
20. Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity
21. Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation
22. Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism
23. Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1
24. SOCS1 is significantly up-regulated in Nutlin-3-treated p53wild-type B chronic lymphocytic leukemia (B-CLL) samples and shows an inverse correlation with miR-155
25. Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors
26. The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL
27. Inverse Correlation Between Circulating Levels of TNF-Related Apoptosis-Inducing Ligand and 17β-Estradiol
28. MitoQ Is Able to Modulate Apoptosis and Inflammation
29. Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients
30. Role of vitamin D in the pathogenesis of atheromatosis
31. MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib
32. Eosinophils and Purinergic Signaling in Health and Disease
33. Colorectal Cancer Study with Nanostructured Sensors: Tumor Marker Screening of Patient Biopsies
34. Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity
35. TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF
36. Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells
37. Crosstalk Between Adipokines and Paraoxonase 1: A New Potential Axis Linking Oxidative Stress and Inflammation
38. TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
39. Targeting mTOR in Acute Lymphoblastic Leukemia
40. Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease
41. TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress
42. The γ-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells
43. Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia
44. Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1
45. Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity
46. C reactive protein down-regulates TNF-related apoptosis inducing ligand expression in human peripheral monocytes via an Egr-1 dependent pathway
47. PEPTIDE-15 STIMULATES PULP STEM CELLS TOWARDS OSTEOBLASTS DIFFERENTIATION
48. Decreased levels of soluble TNF-related apoptosis-inducing ligand (TRAIL) in the conjunctival sac fluid of patients with diabetes affected by proliferative retinopathy
49. Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy
50. The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.